![NSJ Bio/CD137L Antibody / 4-1BBL / TNFSF9 [clone CD137L/1547] (V8184)/100 ug/V8184-100UG](https://www.ebiomall.cn/images/NSJ/img-V8184-100UG-1.jpg)
TNFSF9 / 4-1BBL is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This transmembrane cytokine is a bidirectional signal transducer that acts as a ligand for TNFRSF9 / 4-1BB, which is a costimulatory receptor molecule in T lymphocytes. This cytokine and its receptor are involved in the antigen presentation process and in the generation of cytotoxic T cells. The receptor TNFRSF9 / 4-1BB is absent from resting T lymphocytes but rapidly expressed upon antigenic stimulation. It has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation. This cytokine is required for the optimal CD8 responses in CD8 T cells. This cytokine is expressed in carcinoma cell lines, and is thought to be involved in T cell-tumor cell interaction.
Optimal dilution of the CD137L antibody should be determined by the researcher.
A recombinant full-length human CD137L protein was used as the immunogen for the CD137L antibody.
Store the CD137L antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).